Search clinical trials for: epirubicin - cyclophosphamide / docetaxel trastuzumab
Total 604 results
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Neoplasms | Breast Diseases
-
Krankenhaus NordwestCompleted
-
Hackensack Meridian HealthNational Cancer Institute (NCI)Completed
-
Henan Cancer HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Xinjiang Medical UniversityUnknownDiffuse, Large B-Cell, LymphomaChina
-
Harold J. Burstein, MD, PhDBristol-Myers Squibb; Massachusetts General Hospital; Dana-Farber Cancer Institute and other collaboratorsCompleted
-
Italian Sarcoma GroupFrench Sarcoma Group; Grupo Espanol de Investigacion en SarcomasActive, not recruitingLocalized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in AdultsSpain, Italy
-
University College Hospital, IbadanUniversity of Chicago; Lagos State University; Obafemi Awolowo University Teaching... and other collaboratorsRecruiting
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
Spanish Breast Cancer Research GroupSchering-PloughCompletedBreast CancerSpain
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerChina, United States, Italy, Spain, United Kingdom, Korea, Republic of, Canada, Germany, Poland, Belgium, Japan, Vietnam, Bulgaria, France, Brazil, India, Malaysia, Taiwan, Thailand, Hungary, Australia, Austria, Turkey, Hong Kong, Switz... and more
-
Vall d'Hebron Institute of OncologyHospital del Mar; Clinica Universidad de Navarra, Universidad de Navarra; Puerta... and other collaboratorsRecruiting
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
Merck Sharp & Dohme LLCTerminated
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Aiping ShiRecruitingTriple Negative Breast Cancer (TNBC)China
-
SCRI Development Innovations, LLCAventis PharmaceuticalsCompleted
-
UNICANCERPfizer; NanoString Technologies, Inc.Completed
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
RenJi HospitalUnknownInflammatory Breast Cancer | Invasive Ductal Breast Cancer | Tubular Breast Cancer | Mucinous Breast CancerChina
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
AIO-Studien-gGmbHTaiho Pharmaceutical Co., Ltd.; Nordic Pharma SASCompletedEsophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionGermany
-
Spanish Breast Cancer Research GroupSanofiCompleted
-
George Albert FisherSanofi; GlaxoSmithKlineCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
Shengjing HospitalRecruiting
-
Krankenhaus NordwestGerman Research Foundation; Arbeitsgemeinschaft fur Internistische OnkologieActive, not recruiting
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Fate TherapeuticsRecruitingAdvanced Solid TumorUnited States
-
US Oncology ResearchSanofiCompleted
-
University of MiamiCompleted
-
University of ArkansasGenentech, Inc.Completed
-
Peking Union Medical College HospitalPeking University First Hospital; Chinese PLA General Hospital; Peking University... and other collaboratorsRecruitingT Cell Non-Hodgkin's LymphomaChina
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene CorporationCompletedMalignant Neoplasm of BreastGermany
-
Austrian Breast & Colorectal Cancer Study GroupCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisUnknownBreast CancerUnited States
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
University of ChicagoRecruitingBreast Cancer | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage IIINigeria
-
MedSIRActive, not recruitingBreast CancerSpain, Italy, France, United Kingdom, Germany, Portugal, Belgium
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLCRecruitingHER2-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
NSABP Foundation IncPuma Biotechnology, Inc.CompletedBreast CancerUnited States, Canada, Puerto Rico, Italy, Spain
-
Rita Sanghvi, MehtaCompletedBreast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Emory UniversityPfizerCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedBreast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
University of PisaAzienda Ospedaliero, Universitaria PisanaUnknownGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Colo-rectal Cancer | Liver Cancer | Biliary Tract Cancer | Gall Bladder CancerItaly